3KIM YG, KIM EY, IHM CG, et al. Gene polymor-phisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease[J]. Am J Nephrol,2012,36(5):472-477.
4YOON JW, GOLLAPUDI S, PAHI MV, et al. Naive and central memory T-cell lymphopenia in end-stage renal disease [J]. Kidney Int,2006,70(2):371-376.
5LIU L, KOU P, ZENG Q, et al. CD4+ T lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis[J]. Am J Nephrol,2012,36(4):386-396.
6NDEJEMBI MP, TEIJARO JR, PATKE DS, et al. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway[J]. J Immunol,2006,177(11):7698-7706.
7MUGNAINI EN, EGELAND T, SPURKLAND A, et al. The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time[J]. Clin Exp Immunol,1999,117(2):298-303.
8SANSOM DM, MANZOTTIi CN, ZHENG Y. What′s the difference between CD80 and CD86[J]. Trends Immunol,2003,24(6):314-319.
9BOUR-JORDAN H, BLUESTON JA. CD28 function: a balance of costimulatory and regulatory signals[J]. J Clin Immunol,2002,22(1):1-7.
10WEBB LM, FELDMANN M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells[J]. Blood,1995,86(9):3479-3486.
